On Thursday, Following U.S. Stocks were among the “Top Losers”: Alpha Natural Resources, Inc. (NYSE:ANR), ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), Ascent Solar Technologies, Inc. (NASDAQ:ASTI), Peabody Energy Corp. (NYSE:BTU)

Alpha Natural Resources, Inc.(NYSE:ANR), with shares declined -6.45%, closed at $0.945.

ANI Pharmaceuticals Inc(NASDAQ:ANIP), with shares dropped -5.96 %, settled at $62.16.

Ascent Solar Technologies, Inc.(NASDAQ:ASTI), with shares dipped -5.16%, and closed at $1.19.

Peabody Energy Corporation(NYSE:BTU), plummeted -4.90%, and closed at $5.82.

Latest NEWS regarding these Stocks are depicted underneath:

Alpha Natural Resources, Inc. (NYSE:ANR)

Alpha Natural Resources, Inc. (ANR), holds the market capitalization of 209.41M. The stock return on equity value is -25.10%, while return on assets value is -7.70%, in response to its return on investment value of -12.60%. Its 20-day moving average lost -23.24%, below 50-day moving average of -23.51%, above 200-day moving average of -61.93% from the latest market price of $0.94. This stock is the worst performer for the year indicating yearly performance of -78.67%. The mean recommendation of analysts for this stock is 3.20.(where 1=Buy, 5=Sale).

Alpha Natural Resources, Inc., together with its auxiliaries, engages in extracting, processing, and marketing steam and metallurgical coal in Kentucky, Pennsylvania, Virginia, West Virginia, and Wyoming.

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

ANI Pharmaceuticals, Inc. (ANIP), declared the launch of Etodolac 200mg oral capsules, indicated for use in the administration of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and acute pain. The US market for Etodolac 200mg capsules totals $3 million on a trailing 12 month basis, per IMS Health. Preceding to today’s declaration, only two companies marketed the product. With today’s declaration, ANI now offers both accessible strengths of immediate release Etodolac capsules representing a $12 million market, per IMS Health.

Arthur S. Przybyl, President and Chief Executive Officer said, “We are happy to declare the launch of our third product from the portfolio of approved generic products we attained from Teva in January 2014.”

Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) indicated for acute and long-term use in the administration of signs and symptoms of osteoarthritis and rheumatoid arthritis, and for the administration of acute pain.

ANI Pharmaceuticals, Inc., an integrated specialty pharmaceutical corporation, develops, manufactures, and markets branded and generic prescription pharmaceuticals.

Ascent Solar Technologies, Inc. (NASDAQ:ASTI)

On March 9, Ascent Solar Technologies, Inc. (ASTI), a developer and manufacturer of state-of-the-art, flexible thin-film photovoltaic modules integrated into the corporation’s EnerPlex™ series of consumer products, declared that Rafael Gutierrez has been designated as Senior Vice President & Chief Operating Officer of Ascent Solar.

Mr. Gutierrez was formerly the Senior VP of Sales and Marketing at Ascent Solar from 2009 to 2011. Preceding to that, he had a proven track record of 18 years with Seagate Technologies from 1991 to 2009, where he held various executive positions counting General Manager of Consumer Electronics, Executive Director of Planned Marketing, and Director of Advanced Concepts and Product Development.

After Mr. Gutierrez left Ascent Solar in 2011, he held positions with Ampt, LLC as a Senior VP of Sales and Marketing, and subsequently with Micron Technologies as the Enterprise Business Development Lead before returning to Seagate Technologies in 2013 as the Planned Business Development Lead for Seagate Technology SSD division.

Ascent Solar Technologies, Inc., a development stage corporation, designs and manufactures photovoltaic integrated consumer electronics; and portable power applications for commercial and military users.

Peabody Energy Corp. (NYSE:BTU)

Formerly on March 5, Peabody Energy Corp. (BTU), declared the pricing of its offering of 10.000% senior secured second lien notes due 2022 at an issue price of 97.566% of principal amount. Peabody intends to use the net proceeds from the sale of the notes to fund the formerly declared tender offer to purchase for cash any and all of the $650 million aggregate principal amount outstanding of its 7 3/8% Senior Notes due 2016 (the “2016 notes”), to fund the redemption or satisfaction and discharge of all 2016 notes that are not tendered in the tender offer and for general corporate purposes, which may comprise the payment of its federal coal lease expenditures. The closing of the sale of the notes, which is subject to market and other customary conditions, is predictable to occur on or about March 16, 2015.

Peabody Energy Corporation engages in the mining of coal. The corporation operates through Western U.S. Mining, Midwestern U.S. Mining, Australian Mining, Trading and Brokerage, and Corporate and Other segments.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.